{
    "SPADE_N_15142": {
        "Sequence Information": {
            "Peptide Name": "Gallidermin",
            "Sequence": "IASKFLCTPGCAKXGSFNSYCC",
            "Sequence Length": 22,
            "Biological Activity": [
                "Anti-Gram+",
                "Anti-Gram-",
                "Anti-Mammalian Cell"
            ],
            "Binding Target": "1. Lipid Bilayer",
            "Source": "1. Staphylococcus gallinarum",
            "Gene": "1. gdmA",
            "PDB ID": "",
            "UniProt Entry": [
                {
                    "uniprotId": "P21838",
                    "uniprotUrl": "http://www.uniprot.org/uniprot/P21838",
                    "description": "The amino acid sequence of the current peptide coincides with the part of the UniProt entry that represents a peptide precursor."
                }
            ],
            "Literature": [
                {
                    "Title": "Gallidermin: a new lanthionine-containing polypeptide antibiotic",
                    "Pubmed ID": "3181159",
                    "Reference": "Eur J Biochem. 1988;177:53-59",
                    "Author": "Kellner R, Jung G, Hörner T, Zähner H, Schnell N, Entian KD, Götz F",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/3181159"
                },
                {
                    "Title": "The lantibiotic gallidermin acts bactericidal against Staphylococcus epidermidis and Staphylococcus aureus and antagonizes the bacteria-induced proinflammatory responses in dermal fibroblasts.",
                    "Pubmed ID": "29536668",
                    "Reference": "Microbiologyopen. 2018;7:e00606",
                    "Author": "Bengtsson T, Lönn J, Khalaf H, Palm E",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/29536668"
                }
            ],
            "SPADE ID": "SPADE_N_15142",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_00033",
                    "Similarity": 1.0,
                    "Sequence": "IASKFLCTPGCAKTGSFNSYCC"
                },
                {
                    "SPADE_ID": "SPADE_N_06079",
                    "Similarity": 1.0,
                    "Sequence": "MEAVKEKNELFDLDVKVNAKESNDSGAEPRIASKFLCTPGCAKTGSFNSYCC"
                },
                {
                    "SPADE_ID": "SPADE_N_00024",
                    "Similarity": 0.9523809523809523,
                    "Sequence": "IASKFICTPGCAKTGSFNSYCC"
                }
            ],
            "Hemolytic Activity": "",
            "Target Organism": "Staphylococcus aureus SG511(MIC=4µg/ml),Staphylococcus aureus(MIC=8µg/ml),Staphylococcus epidermidis ATCC 12228(MIC=4µg/ml),Streptococcus pneumoniae ATCC 6302(MIC=4µg/ml),Streptococcus pyogenes ATCC 8668(MIC=1µg/ml),Enterococcus faecalis ATCC 29212(MIC=64µg/ml),Corynebacterium xerosis ATCC 9755(MIC=1µg/ml),Escherichia coli ATCC 11775(MIC=128µg/ml),Pseudomonas aeruginosa(MIC=128),Micrococcus luteus ATCC 9341(MIC=0.25µg/ml),Micrococcus luteus(MIC=0.5µg/ml),Bacteroides fragilis(MIC=128µg/ml),Peptostreptococcus anaerobius(MIC=0.5µg/ml),Cutibacterium acnes(MIC=0.125µg/ml),Staphylococcus epidermidis ATCC 12228(MIC=6.25µg/ml),Staphylococcus epidermidis RP62A(MIC=6.25µg/ml),Staphylococcus aureus ATCC 29213(MIC=12.5µg/ml),Staphylococcus aureus CCUG 35601(MIC=1.56µg/ml),Staphylococcus epidermidis ATCC 12228(MBC=6.25µg/ml),Staphylococcus epidermidis RP62A(MBC=6.25µg/ml),Staphylococcus aureus ATCC 29213(MBC=12.5µg/ml),Staphylococcus aureus CCUG 35601(MBC=1.56µg/ml)"
        }
    }
}